Mometasone Sandoz (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasone Sandoz, is a corticosteroid presented as a nasal spray for intranasal administration. It is indicated for the relief of symptoms of allergic rhinitis, including nasal congestion, sneezing and itching, in both adult and pediatric patients.

GNH USA supplies Mometasone Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for regulated markets. The product complies with EU marketing authorisation standards and is manufactured under strict quality controls globally.

Mometasone furoate nasal spray is used to treat inflammatory conditions of the nasal passages associated with allergic reactions. - Allergic rhinitis: reduces nasal congestion, sneezing, itching and rhinorrhea. - Seasonal allergic rhinitis: provides symptom relief during pollen exposure. - Nasal congestion due to allergic rhinitis: improves airflow by decreasing mucosal edema.

Mometasone furoate nasal spray may cause local and systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation: mild burning or stinging. - Epistaxis: occasional nosebleeds. - Headache: transient headache. - Throat dryness: mild soreness.

Serious or Rare Side Effects: - Nasal septal perforation: rare tissue damage. - Secondary infection: fungal or bacterial sinusitis. - Adrenal suppression: possible systemic effect with prolonged high‑dose use.

When prescribing Mometasone furoate nasal spray, clinicians should consider several safety and handling precautions. - Indication verification: confirm diagnosis of allergic rhinitis before use. - Duration of therapy: limit continuous use to recommended period, usually not exceeding several weeks without reassessment. - Pediatric use: use only as directed for children above the approved age. - Concomitant infections: avoid use if active nasal or sinus infection is present. - Systemic effects monitoring: watch for signs of adrenal suppression or intra‑ocular pressure increase with long‑term therapy. - Store at room temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Mometasone furoate nasal spray can interact with other medicines, primarily affecting systemic corticosteroid exposure or local nasal conditions.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use may increase risk of systemic glucocorticoid effects. - CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug levels, increasing adverse effect risk.

Moderate Interactions (Monitor Closely): - Nasal decongestants: combined use may mask underlying infection. - Antifungal nasal sprays: potential additive irritation. - Immunosuppressants: monitor for enhanced immunosuppression.